Brachytherapy for prostate cancer in Turkey typically costs from AUD $3,547 to AUD $7,804 on average. The final price depends on the radiation dose, the specific technique used, and the hospital location. In Australia, this treatment averages around AUD $25,541, meaning patients can save approximately 78%. Most Turkish oncology centres include specialist consultations and airport transfers in their care packages.
Bookimed Expert Insight: Choosing a Turkish centre with international ties can provide exceptional value for money. Anadolu Medical Center, for instance, maintains an affiliation with Johns Hopkins Hospital from the USA. This ensures treatments follow stringent global oncology standards. Leading Istanbul hospitals like Medipol Mega University Hospital also use advanced tools like Gamma Knife, providing high-precision alternatives if clinical needs change.
| Turkey | Thailand | South Korea | |
| Brachytherapy for prostate cancer | from AUD $3,547 | from AUD $15,608 | from AUD $19,582 |
The doctor graduated from the School of Medicine at Hacettepe University and completed residency at Istanbul Sisli Etfal Training and Research Hospital, followed by a fellowship at the Hacettepe University Cancer Institute.
Specializing in oncology, the doctor has extensive experience in treating various cancers, including breast, testicular, ovarian, lung, head and neck, and gastrointestinal cancers.
The doctor has worked at prestigious institutions such as The University of Texas MD Anderson Cancer Center, Hitit University Corum Training Hospital, and Medical Park Hospital.
The doctor is an Urological Oncologist specializing in Minimal Invasive Surgery, Neo-Bladder Reconstruction, and Urological Cancer at Anadolu Medical Center. With a Bachelor Degree from Istanbul University and a Residency in Urology from Marmara University, the doctor has been recognized with several awards, including the Science Encouragement Award for Residency Students in 2008 and the Young Academic Presentation Award in 2012.
The doctor is an Executive Board Member of the Association of Urooncology and Secretary of the Bladder Tumours Research Group. Additionally, the doctor is a member of the International Bladder Cancer Network, European Association of Urology, and the American College of Surgeons.